Ondansetron is a selective 5-HT3 receptor antagonist that may provide relief in cluster headache by modulating serotonergic neurotransmission and reducing neural inflammation. While primarily used as an antiemetic, it can potentially interrupt the complex neurological mechanisms underlying cluster headache pathogenesis by blocking serotonin receptors in the trigeminovascular system.